PROF. JOEL GELERNTER, MD
Psychiatric in New Haven, CT
License number
Connecticut 029404
Category
Psychiatric
Type
Psychiatry
Address
Address
950 Campbell Avenue Va Ct Healthcare Ctr, New Haven, CT 06516
Phone
(203) 932-5711
Personal information
See more information about JOEL GELERNTER at radaris.comName
Address
Phone
11 Hemlock Hollow Rd, Woodbridge, CT 06525
129 Curtis Dr, New Haven, CT 06515
11 Hemlock Hollow Rd, Woodbridge, CT 06525
129 Curtis Dr, New Haven, CT 06515
1 Deerfield Ln, Ansonia, CT 06401
Organization information
See more information about JOEL GELERNTER at bizstanding.comJoel Gelernter MD
950 Campbell Ave, West Haven, CT 06516
Industry:
Psychiatrist
Phone:
(203) 932-5711 (Phone)
Joel Eli Gelernter
Professional information
Joel Eli Gelernter, West Haven CT
Specialties:
Psychiatrist
Address:
950 Campbell Ave, West Haven, CT 06516
Education:
State University of New York Downstate Medical Center, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
Dr. Joel Gelernter, West Haven CT - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
VA Cnnctct Hlthcr Sys Psychtry
950 Campbell Ave SUITE 116A, West Haven 06516
(203) 932-5711 (Phone)
950 Campbell Ave SUITE 116A, West Haven 06516
(203) 932-5711 (Phone)
Certifications:
Psychiatry, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Suny Downstate Medical Center
Graduated: 1983
SUNY Stony Brook
Graduated: 1984
Suny Downstate Medical Center
Graduated: 1983
SUNY Stony Brook
Graduated: 1984
Treatment Response In Generalized Social Phobia
US Patent:
2009022, Sep 3, 2009
Filed:
Feb 14, 2007
Appl. No.:
12/279178
Inventors:
Murray B. Stein - San Diego CA, US
Joel Gelernter - Woodbridge CT, US
Joel Gelernter - Woodbridge CT, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
This invention generally pertains to the field of psychiatry. In particular, this invention relates to, inter alia, the discovery that a subject's serotonin transporter gene promoter polymorphism genotype can be used to determine the subject's response to certain drug therapies.
Diagnosis Of Anxiety Disorders
US Patent:
2009020, Aug 20, 2009
Filed:
Nov 21, 2007
Appl. No.:
11/986553
Inventors:
Jordan W. Smoller - Newton MA, US
Martin P. Paulus - La Jolla CA, US
Joel Gelernter - New Haven CT, US
Murray B. Stein - La Jolla CA, US
Martin P. Paulus - La Jolla CA, US
Joel Gelernter - New Haven CT, US
Murray B. Stein - La Jolla CA, US
International Classification:
C12Q 1/68, C07H 21/04, A61K 31/7088, A61P 25/24
US Classification:
514 44 A, 435 6, 536 243
Abstract:
The invention relates to methods for diagnosing a genetic predisposition or susceptibility for anxiety disorders in a human. The methods include detecting particular markers at the human RGS2 locus in a sample obtained from the human. The invention also relates to the improved diagnosis that is based on the analysis of haplotypes for the RGS2 locus.